Showing results (91-100 of 96) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
The Lancet. Oncology|March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)Emily Alger, Antoine Regnault, Amylou C Dueck, et al.Trials|February 26, 2025
Guidelines for the content of statistical analysis plans in clinical trials: protocol for an extension to cluster randomized trialsKarla Hemming, Jacqueline Y Thompson, Richard L Hooper, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 19, 2003
Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset ADAmanda J Myers, Helen Marshall, Peter Holmans, et al.American Heart Journal|August 10, 2018
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trialOmar Mukhtar, Joseph Cheriyan, John R Cockcroft, et al.Lancet (London, England)|September 21, 2025
Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trialChantal Mathieu, Julie Wych, A Emile J Hendriks, et al.Plos Medicine|October 12, 2016
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialJohn A Todd, Marina Evangelou, Antony J Cutler, et al.Pageof 10